RUA Life Sciences (LON:RUA) Shares Down 0.8% – What’s Next?

RUA Life Sciences plc (LON:RUAGet Free Report) shares fell 0.8% during mid-day trading on Monday . The stock traded as low as GBX 12.49 and last traded at GBX 12.49. 52,657 shares traded hands during mid-day trading, a decline of 63% from the average session volume of 144,143 shares. The stock had previously closed at GBX 12.59.

RUA Life Sciences Stock Down 0.8%

The business’s 50 day moving average price is GBX 11.80 and its 200-day moving average price is GBX 11.71. The company has a debt-to-equity ratio of 5.42, a quick ratio of 7.32 and a current ratio of 9.01. The firm has a market capitalization of £7.75 million, a PE ratio of -2.61 and a beta of 1.21.

RUA Life Sciences Company Profile

(Get Free Report)

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.

Featured Articles

Receive News & Ratings for RUA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RUA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.